No Data
No Data
Sano Healthcare: 2025-005: Sano Healthcare Science & Technology Co., Ltd. 2024 Annual Performance Report Announcement
2025-005: Sano Medical Science & Technology Co., Ltd. 2024 Annual Performance Report Announcement
Sales of two centralized procurement products have increased significantly. Sino Medical Sciences Technology Inc. is expected to turn a profit in 2024, and the Brackets are anticipated to obtain registration certification within the year.
① The company's new spiny balloon product also started large-scale sales in 2024, but the admission rate for the spiny balloon is lower than expected; ② The subsidiary Sinopharm ShenChang officially began production in the second quarter of 2023. Due to the short period of production, the capacity utilization rate is relatively low, resulting in higher fixed costs allocated per unit product.
Sino Medical Sciences Technology Inc. (688108.SH): Net income of 1.5211 million yuan in 2024, turning a loss into profit year-on-year.
Gelonghui, February 26丨Sino Medical Sciences Technology Inc. (688108.SH) announced the performance report for 2024. During the reporting period, the company achieved total revenue of 458.7393 million yuan, an increase of 33.64% compared to the same period last year; achieved a net income attributable to the parent company's shareholders of 1.5211 million yuan, an increase of 103.84% compared to the same period last year; achieved a net income attributable to the parent company's shareholders, excluding non-recurring gains and losses of -17.5065 million yuan, an increase of 64.79% compared to the same period last year. During this reporting period, the company's losses were significantly reduced compared to the same period last year, primarily due to the substantial year-on-year growth in revenue.
Sino Medical Sciences Technology Secures Regulatory Approvals in Argentina, Ecuador for Medical Devices
Sino Medical Sciences Technology (SHSE:688108) Shareholder Returns Have Been Decent, Earning 51% in 3 Years